Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Reportlinker Adds Western European Disinfectant Gels and Scrubs Market

July 19, 2010 11:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK , July 19 /- Reportlinker.com announces that a new market research report is available in its catalogue: Western European Disinfectant Gels and Scrubs Market http://www.reportlinker.com/p0239932/Western-European-Disinfectant-Gels-and-Scrubs-Market.html This re...

TOPICS:

New Study Shows Meganuclease-Driven Targeted Integration Using Cellectis bioresearch's cGPS® CHO-K1 Kit to be Highly Efficient for Drug Discovery

July 19, 2010 11:34 am | by Bio-Medicine.Org | News | Comments

PARIS , July 19 /- Cellectis bioresearch, a specialist in genome customization and a subsidiary of Cellectis (Alternext: ALCLS), today announced the publication of a scientific study describing a novel method, based on meganuclease-driven targeted integration, for the generation of stable...

TOPICS:

Mindray Medical Provides Mid-Year Update on Product Development

July 19, 2010 11:34 am | by Bio-Medicine.Org | News | Comments

SHENZHEN, China , July 19 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR ), a leading developer, manufacturer and marketer of medical devices worldwide, today announced updates on new product launches for the first half of 2010. In the first half of the...

TOPICS:
Advertisement

Reportlinker Adds European Market for Ventilation and Airway Management Devices

July 19, 2010 11:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK , July 19 /- Reportlinker.com announces that a new market research report is available in its catalogue: European Market for Ventilation and Airway Management Devices http://www.reportlinker.com/p0239929/European-Market-for-Ventilation-and-Airway-Management-Devices.html...

TOPICS:

ICAP Ocean Tomo Offers for Sale IP Portfolio of Active Implants for Electromagnetic Bone and Tissue Regeneration in Orthopedics, Trauma, and Wound Care

July 19, 2010 11:34 am | by Bio-Medicine.Org | News | Comments

CHICAGO , July 19 /- ICAP Ocean Tomo , the intellectual property brokerage division of ICAP plc (IAP.L), is offering for sale a patent portfolio of active implants for electromagnetic bone and tissue regeneration in orthopedics, trauma, and wound care.  Developed by Magentodyn, the...

TOPICS:

AVAC Praises CAPRISA 004 Trial Collaborators and Participants for Historic Study - Trial Confirms Promise of ARV-Based Microbicides

July 19, 2010 11:33 am | by Bio-Medicine.Org | News | Comments

VIENNA , July 19 /PRNewswire-USNewswire/ -- "This is a historic day for HIV prevention research. The CAPRISA 004 results are the first clinical evidence that a microbicide gel can help to prevent sexual transmission of HIV infection," said AVAC Executive Director Mitchell Warren ,...

TOPICS:

Earnings Preview: Boston Scientific

July 19, 2010 9:45 am | by The Associated Press | News | Comments

Medical device maker Boston Scientific Corp. reports its second-quarter earnings Tuesday after markets close.WHAT TO WATCH FOR: Analysts and investors will continue to watch sales of the company's heart-pacing implants. Boston Scientific stumbled in March when it suspended sales of its two...

Medtronic paid CEO $9M in fiscal 2010

July 19, 2010 7:45 am | by MATTHEW PERRONE - AP Business Writer - Associated Press | News | Comments

Medtronic Inc., the world's largest medical device maker, paid Chief Executive William Hawkins $9 million in total compensation for fiscal 2010, roughly even with his earnings in the prior year, according to an analysis by the Associated Press.Hawkins, 56, took the reins of Medtronic in 2008,...

Advertisement

BD Biosciences Introduces CD4 Testing Product That Does Not Require Refrigeration

July 19, 2010 7:34 am | by Becton, Dickinson and Company | News | Comments

(July 19, 2010) -- BD Biosciences, a segment of BD (Becton, Dickinson and Company), today announced the creation of new dried reagents developed through a collaboration with ReaMetrix, a private biotechnology company based in Bangalore, India.  The new reagent

TOPICS:

World's Largest Study on Insulin Therapy Completes Recruitment With 60,000 Patients

July 19, 2010 6:38 am | by Bio-Medicine.Org | News | Comments

ZURICH , July 19, 2010 /- Today, Novo Nordisk announced the landmark recruitment of the 60,000th patient in the A1chieve(R) study - an observational study designed to investigate the effects of modern insulins in the management of type 2 diabetes.[1] Spanning 28 countries across 4...

TOPICS:

Visage Imaging Releases Amira 5.3

July 19, 2010 6:35 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Calif. , July 19 /- Visage Imaging®, Inc., a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), is pleased to announce the immediate release of Amira 5.3, a new major version of its market-leading software platform for visualizing, analyzing, and presenting complex 3D...

TOPICS:

Adaptation in mole blood aids tunnelling

July 19, 2010 6:34 am | by EurekAlert | News | Comments

(BioMed Central) "Super hemoglobin" allows moles to thrive underground. Researchers writing in the open-access journal BMC Evolutionary Biology have made the first identification of an adaptation in the blood of Eastern moles which allows more efficient transport of carbon dioxide,...

TOPICS:

New biotech company grows from MCG diabetes and genomic research

July 19, 2010 6:34 am | by EurekAlert | News | Comments

(Medical College of Georgia) A new biotech company has grown out of laboratory and clinical studies at the Medical College of Georgia with the goal of improving the diagnosis and treatment of diabetes and cancer. Dr. Jin-Xiong She, director of the MCG Center for Biotechnology and...

TOPICS:

Slim- 30 Herb Supplement: Undeclared Drug Ingredient

July 19, 2010 6:30 am | by U.S. Food & Drug Administration | News | Comments

Product found to contain undeclared N-Desmethyl Sibutramine and traces of Sibutramine.

TOPICS:

MDMA (Ecstasy)-assisted psychotherapy relieves treatment-resistant PTSD

July 19, 2010 4:31 am | by EurekAlert | News | Comments

(SAGE Publications UK) MDMA (also known as Ecstasy), may one day offer hope for individuals with posttraumatic stress disorder (PTSD), even people for whom other treatments have failed. Clinical trial results out today in the Journal of Psychopharmacology, published by SAGE,...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading